Get the BNN Bloomberg App now Sign up for the Market Call Top Picks newsletter at bnnbloomberg.ca/subscribe Amgen offers wide ...

Novo Nordisk NVO announced positive data from a sub-analysis of its phase III REDEFINE 1 study assessing the efficacy and ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Shares of the company ended 1.6% lower at a price of ₹354.40 on the BSE. Last week's losses have dragged the stock 4% lower ...

The once-daily oral GLP-1 RA orforglipron produces clinically and statistically significant weight loss and cardiometabolic ...

Backed by a trio of top venture firms, Ollin is working on a pair of medicines it believes can one-up Roche’s Vabysmo and Amgen’s Tepezza.

Amgen Inc. has seen a notable increase in its stock holdings, with Legacy Private Trust Co. boosting its stake by 13.6%. The ...